Twitter | Pretraživanje | |
Trevor Martin
Co-founder & CEO | Fortune 40U40 | Forbes 30U30 | previously PhD; BA
188
Tweetovi
38
Pratim
702
Osobe koje vas prate
Tweetovi
Trevor Martin proslijedio/la je tweet
Mammoth Biosciences 31. sij
Hot on the tail of our successful Series B announcement, we’ve opened up many new positions at Mammoth! Visit to find openings for Research Associates, Scientists, Product Development roles, & a Director of .
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Jeff Huber 31. sij
Huge congrats to , , , Jennifer Doudna, and the whole Team on great progress building the platform for CRISPR Dx & Tx, and Min Cui/ Decheng, , and on Series B funding! I'm honored to join the Board.
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
TechCrunch 30. sij
Mammoth Biosciences aims to be Illumina for the gene editing generation by
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin 30. sij
Excited to announce our oversubscribed $45M Series B to advance 's next-generation CRISPR Platform into both diagnostic and therapeutic products! A testament to the great team we're building at Mammoth and an exciting start to a busy year.
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Xconomy 30. sij
With $45M, Expects Big Things From Tiny CRISPR Cas14 - by ; insight from CEO
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Tectonic Capital 30. sij
Excited to share our portfolio company today announced a $45M Series B to develop the next generation of CRISPR products. We’re thrilled to support their expansion of applications for diagnostics, therapeutics + more. Read more via :
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Forbes Under 30 30. sij
Big funding news from this company @
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Mammoth Biosciences 30. sij
Proud to announce our $45M Series B to expand our platform into therapeutics & broaden access to our IP to develop clinical applications w/ unprecedented speed/accuracy. Thanks to & all our investors. Read more via :
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
BioCentury 30. sij
Gene editing company Mammoth plans to leverage its IP position and $45M B round to expand from diagnostics to therapeutics
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
VSC 30. sij
Congrats to our friends on raising their $45 M Series B to build the next generation of CRISPR tools for , , , and beyond. Read more via :
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Endpoints News 30. sij
Doudna-founded CRISPR upstart bags $45M for new Cas family, extends its reach into therapeutics
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Mayfield 30. sij
. is working with to develop a quicker diagnostic test to stop the spread of the disease:
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
FinSMEs 30. sij
Mammoth Biosciences Raises $45M in Series B Funding Round
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Forbes 30. sij
Mammoth Biosciences, a company founded by members that uses gene-editing technology Crispr for disease testing, raised $45 million—and its tech is already being used against coronavirus
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
NFX 30. sij
NFX company Mammoth , the world's 1st CRISPR-based disease detection platform co-Founded by , CRISPR pioneer Jennifer Doudna, + others announces a $45 Million Series B to fuel expansion into next-gen therapeutics & gene editing.
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Mayfield 30. sij
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Mammoth Biosciences 28. sij
Mammoth Co-Founder Janice Chen did a fantastic job chairing the "How CRISPR Revolutionizes Genomic Medicine" panel at ! She led a candid conversation about 's potential and the challenges behind bring impactful CRISPR technologies to market.
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Mammoth Biosciences 27. sij
The cas proteins are very careful about curating their online presence
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Tyler J Ford 24. sij
Last session for the day at - “How revolutionizes genomic medicine” chaired by co-founder
Reply Retweet Označi sa "sviđa mi se"
Trevor Martin proslijedio/la je tweet
Mammoth Biosciences 24. sij
We’re hiring! Do you have experience bringing to market and want to work with a collaborative and driven team? Then apply for our Product Manager position!
Reply Retweet Označi sa "sviđa mi se"